UBS Group’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
15,200
-3,465
| -19% | -$117K | ﹤0.01% | 4823 |
|
|
2025
Q1 | $594K | Sell |
18,665
-2,396
| -11% | -$76.2K | ﹤0.01% | 4561 |
|
|
2024
Q4 | $818K | Sell |
21,061
-14
| -0.1% | -$544 | ﹤0.01% | 4360 |
|
|
2024
Q3 | $948K | Sell |
21,075
-1,925
| -8% | -$86.6K | ﹤0.01% | 3628 |
|
|
2024
Q2 | $960K | Sell |
23,000
-811
| -3% | -$33.9K | ﹤0.01% | 3436 |
|
|
2024
Q1 | $1.08M | Sell |
23,811
-654
| -3% | -$29.8K | ﹤0.01% | 3496 |
|
|
2023
Q4 | $1.13M | Buy |
24,465
+647
| +3% | +$29.9K | ﹤0.01% | 3343 |
|
|
2023
Q3 | $969K | Sell |
23,818
-1,946
| -8% | -$79.2K | ﹤0.01% | 3104 |
|
|
2023
Q2 | $1.25M | Sell |
25,764
-447
| -2% | -$21.7K | ﹤0.01% | 3103 |
|
|
2023
Q1 | $1.29M | Sell |
26,211
-1,087
| -4% | -$53.6K | ﹤0.01% | 2971 |
|
|
2022
Q4 | $1.38M | Sell |
27,298
-7,508
| -22% | -$380K | ﹤0.01% | 2876 |
|
|
2022
Q3 | $1.75M | Sell |
34,806
-6,116
| -15% | -$307K | ﹤0.01% | 2449 |
|
|
2022
Q2 | $2M | Sell |
40,922
-66,573
| -62% | -$3.26M | ﹤0.01% | 2390 |
|
|
2022
Q1 | $6.46M | Sell |
107,495
-56,913
| -35% | -$3.42M | ﹤0.01% | 1731 |
|
|
2021
Q4 | $13.1M | Sell |
164,408
-13,928
| -8% | -$1.11M | ﹤0.01% | 1371 |
|
|
2021
Q3 | $15.8M | Buy |
178,336
+4,244
| +2% | +$376K | 0.01% | 1254 |
|
|
2021
Q2 | $17.3M | Sell |
174,092
-14,565
| -8% | -$1.45M | 0.01% | 1194 |
|
|
2021
Q1 | $17M | Buy |
188,657
+54,603
| +41% | +$4.91M | 0.01% | 1154 |
|
|
2020
Q4 | $12.7M | Buy |
134,054
+28,091
| +27% | +$2.65M | ﹤0.01% | 1261 |
|
|
2020
Q3 | $7.62M | Buy |
105,963
+36,878
| +53% | +$2.65M | ﹤0.01% | 1442 |
|
|
2020
Q2 | $4.85M | Buy |
69,085
+54,029
| +359% | +$3.8M | ﹤0.01% | 1630 |
|
|
2020
Q1 | $750K | Buy |
15,056
+14,202
| +1,663% | +$707K | ﹤0.01% | 2885 |
|
|
2019
Q4 | $53K | Buy |
+854
| New | +$53K | ﹤0.01% | 5271 |
|